NUMD
Nu-Med Plus, Inc.Company Information
- Company Name
- Nu-Med Plus, Inc.
- CIK
- CIK0001543637
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NUMD: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- NUMD
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 51.32%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | -0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
Assets Current | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | - | - | 0 | 0 | - | 0 | 0 | ||||||
| Cash | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Long Term Assets | ||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||
| Property Plant And Equipment Net | - | 0 | - | - | - | - | - | - | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Long Term Liabilities | ||||||||||||||
| Long Term Debt Noncurrent | 0 | 0 | - | - | - | - | - | - | ||||||
| Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Commitments And Contingencies | 0 | - | - | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||
| Preferred Stock Value | 0 | 0 | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Retained Earnings Accumulated Deficit | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | ||||||
| Stockholders Equity | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | ||||||
| Common Stock Shares Issued | 84 | 84 | 84 | 84 | 84 | 84 | 84 | 81 | ||||||
| Shares Outstanding | 84 | 84 | 84 | 84 | 84 | 84 | 84 | 81 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNu-Med Plus, Inc. (NUMD) — SEC Financial Statements & Analysis
Nu-Med Plus, Inc. (NUMD) is a surgical & medical instruments & apparatus company, incorporated in UT. Nu-Med Plus, Inc. trades on OTC as: NUMD. Nu-Med Plus, Inc. (NUMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Nu-Med Plus, Inc. carries a market cap of $967.49K, a P/E ratio of -40.23x, a P/B ratio of -3.62x, an enterprise value of $1.06M, and an EV/EBITDA multiple of -17.40x. On profitability, it posts a Return on Equity (ROE) of 10.19% and a Return on Assets (ROA) of -243.54%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -78.81% year-over-year and EPS growth of -79.37% year-over-year. On the balance sheet, it maintains a current ratio of 0.05x, a quick ratio of 0.02x, working capital of $-267.49K, a debt-to-equity ratio of -1.05x, a debt ratio of 21.72, an interest coverage ratio of -6.60x, free cash flow of $-6.92K (TTM), and net debt of $94.59K. Figures sourced from SEC EDGAR.
- Market Cap
- $967.49K
- P/E TTM
- -40.23x
- EPS TTM
- $-0.00
- P/B TTM
- -3.62x
- ROE TTM
- 10.19%
- ROA TTM
- -243.54%
- Debt To Equity
- -1.05x
- Free Cash Flow TTM
- $-6.92K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Nu-Med Plus, Inc. in?
Nu-Med Plus, Inc. (NUMD) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does NUMD trade on?
Nu-Med Plus, Inc. (NUMD) trades on the OTC.
Where is Nu-Med Plus, Inc. incorporated?
Nu-Med Plus, Inc. is incorporated in UT.
When was Nu-Med Plus, Inc. (NUMD)'s most recent SEC filing?
Nu-Med Plus, Inc. (NUMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is NUMD's market cap?
Nu-Med Plus, Inc. (NUMD) has a market capitalization of $967.49K as of 2026-06-30.
What is NUMD's EPS (earnings per share)?
Nu-Med Plus, Inc. (NUMD)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is NUMD's ROE (return on equity)?
Nu-Med Plus, Inc. (NUMD)'s trailing twelve month Return on Equity (ROE) is 10.19% as of 2026-06-30.
What is NUMD's ROA (return on assets)?
Nu-Med Plus, Inc. (NUMD)'s trailing twelve month Return on Assets (ROA) is -243.54% as of 2026-06-30.
What is NUMD's EV/EBITDA?
Nu-Med Plus, Inc. (NUMD)'s trailing twelve month EV/EBITDA is -17.40x as of 2026-06-30.